CS253734B2 - Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid - Google Patents

Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid Download PDF

Info

Publication number
CS253734B2
CS253734B2 CS859449A CS944985A CS253734B2 CS 253734 B2 CS253734 B2 CS 253734B2 CS 859449 A CS859449 A CS 859449A CS 944985 A CS944985 A CS 944985A CS 253734 B2 CS253734 B2 CS 253734B2
Authority
CS
Czechoslovakia
Prior art keywords
tartaric acid
dobutamine
methylpropyl
ethylamine
salt
Prior art date
Application number
CS859449A
Other languages
Czech (cs)
English (en)
Inventor
Eddie H Massey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS253734B2 publication Critical patent/CS253734B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/06Glycolic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10Polyhydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/10Polyhydroxy carboxylic acids
    • C07C59/105Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255Tartaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/285Polyhydroxy dicarboxylic acids having five or more carbon atoms, e.g. saccharic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Seasonings (AREA)
CS859449A 1984-12-20 1985-12-18 Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid CS253734B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68440484A 1984-12-20 1984-12-20

Publications (1)

Publication Number Publication Date
CS253734B2 true CS253734B2 (en) 1987-12-17

Family

ID=24747892

Family Applications (1)

Application Number Title Priority Date Filing Date
CS859449A CS253734B2 (en) 1984-12-20 1985-12-18 Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid

Country Status (24)

Country Link
EP (1) EP0187019B1 (ro)
JP (1) JPS61155355A (ro)
KR (1) KR870000803B1 (ro)
CN (1) CN1009922B (ro)
AT (1) ATE58370T1 (ro)
AU (1) AU589929B2 (ro)
CA (1) CA1254909A (ro)
CS (1) CS253734B2 (ro)
DD (1) DD241071A5 (ro)
DE (2) DE3580575D1 (ro)
DK (1) DK589385A (ro)
EG (1) EG17889A (ro)
ES (2) ES8705841A1 (ro)
FI (1) FI855018A (ro)
GR (1) GR853027B (ro)
HU (1) HU194805B (ro)
MY (1) MY104814A (ro)
NZ (1) NZ214583A (ro)
PH (1) PH22547A (ro)
PL (1) PL148296B1 (ro)
PT (1) PT81705B (ro)
RO (1) RO93391B (ro)
SU (1) SU1480761A3 (ro)
ZA (1) ZA859629B (ro)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
FR2740337B1 (fr) * 1995-10-27 1997-11-21 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant un derive ayant une activite adrenergique
FR2740338B1 (fr) * 1995-12-01 1997-12-05 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees contenant de la dobutamine
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
CN105906515B (zh) * 2015-12-10 2018-03-13 菏泽市方明制药有限公司 一种盐酸多巴酚丁胺脱色工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
FR2333499A1 (fr) * 1975-12-01 1977-07-01 Roussel Uclaf Nouveau derive de la phenethylamine et ses sels, procede de preparation et application a titre de medicament

Also Published As

Publication number Publication date
EP0187019A3 (en) 1987-09-30
SU1480761A3 (ru) 1989-05-15
ES8802570A1 (es) 1988-08-01
ES550151A0 (es) 1987-05-16
ES8705841A1 (es) 1987-05-16
DK589385D0 (da) 1985-12-18
RO93391B (ro) 1988-03-31
JPH0327544B2 (ro) 1991-04-16
EP0187019A2 (en) 1986-07-09
DE187019T1 (de) 1987-11-26
DK589385A (da) 1986-06-21
FI855018A0 (fi) 1985-12-17
CN1009922B (zh) 1990-10-10
DE3580575D1 (en) 1990-12-20
CN85109229A (zh) 1986-10-01
PT81705A (en) 1986-01-01
ATE58370T1 (de) 1990-11-15
EP0187019B1 (en) 1990-11-14
HU194805B (en) 1988-03-28
NZ214583A (en) 1989-04-26
DD241071A5 (de) 1986-11-26
GR853027B (ro) 1986-04-18
JPS61155355A (ja) 1986-07-15
FI855018A (fi) 1986-06-21
AU5141585A (en) 1986-06-26
PT81705B (pt) 1988-04-21
PH22547A (en) 1988-10-17
PL148296B1 (en) 1989-10-31
EG17889A (en) 1991-03-30
MY104814A (en) 1994-04-30
KR870000803B1 (ko) 1987-04-20
AU589929B2 (en) 1989-10-26
PL256848A1 (en) 1986-10-21
CA1254909A (en) 1989-05-30
HUT40069A (en) 1986-11-28
RO93391A (ro) 1988-03-30
ES557426A0 (es) 1988-08-01
ZA859629B (en) 1987-07-29
KR860004834A (ko) 1986-07-14

Similar Documents

Publication Publication Date Title
US3266987A (en) Substituted thiourea compounds and methods of using same as anthelmintics
Lee et al. Properties of the laryngeal chemoreflex in neonatal piglets
Hillman et al. The use of dicobalt edetate (Kelocyanor) in cyanide poisoning
US2848366A (en) Non-hydrated ferrous fumarate and hematinic composition thereof
CS253734B2 (en) Process for preparing salt of n-/3-4/4-hydroxyphenyl/-1-methylpropyl/-2-/3,4-dihydroxyphenyl/ethylamine with tartaric acid
DE2519005A1 (de) Verfahren zur diagnostischen sichtbarmachung von neoplastischen geweben
DE4130061A1 (de) Furanderivate enthaltende pharmazeutische praeparate
US4151188A (en) Arsenamide compound
US3903285A (en) Method for treating parkinsonism
Dakin The behaviour of hypochlorites on intravenous injection and their action on blood serum
DE2034640C3 (de) l-p-(7-Trifluormethyl-4-chinolyl) -amino-benzoyl-piperazine, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Bluthochdruck
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
Hull et al. The antagonism of adrenergic blockade by dichloroisoproterenol (DCI)
Stanley et al. Cobalt polycythemia. II. Relative effects of oral and subcutaneous administration of cobaltous chloride
US3459854A (en) Tetracycline cyclohexyl sulphamate and process for preparation
US3138529A (en) Tetracycline antibiotic compositions for oral use
US2678899A (en) Stable solution of physostigmine
Mandel et al. Diphenidol: a new agent for the treatment of digitalis-induced arrhythmias electrophysiologic and hemodynamic studies
DE3878494T2 (de) Mittel gegen zuckerkrankheit.
KONCHIGERI et al. Effect of epinephrine during enflurane anesthesia
KR800000452B1 (ko) 벤젠설포닐-우레아의 제조방법
RU2021260C1 (ru) Соли акриловой кислоты, проявляющие цитопротекторную и противоязвенную активность, и состав, обладающий цитопротекторной и противоязвенной активностью
JPS6129324B2 (ro)
SU621148A1 (ru) Вещество, антикоагул нтную активность
US3679802A (en) Method of preventing convulsions